10-Q: Firsthand Technology Value Fund Reports Net Asset Decline
Quarterly Report
Firsthand Technology Value Fund, Inc. disclosed a significant decrease in net assets and substantial unrealized depreciation, alongside a going concern warning in its latest SEC filing.
Summary
- The company reported a net asset value of $(447,081) as of June 30, 2026, a significant decrease from $(235,128) as of December 31, 2025.
- Total investment income for the three months ended June 30, 2026, was $214, a sharp drop from $170,861 in the same period of the prior year.
- Operating expenses for the three months ended June 30, 2026, were $(6,061), compared to $234,035 in the prior year period, largely due to a net legal fees reimbursement.
- The six-month period ended June 30, 2026, saw a net investment loss of $177,824, compared to a similar loss of $176,392 in the prior year period.
- A substantial net unrealized depreciation of $89,713,527 was reported as of June 30, 2026.
- The filing includes a going concern warning, citing the excess of liabilities over assets and recent operating losses.
Sentiment
Score: 2
Explanation: StockSavvy.ai views this filing as negative due to the significant net asset decline, substantial unrealized depreciation, and the going concern warning, indicating considerable financial distress.
Positives
- A net legal fees reimbursement of $86,624 positively impacted operating expenses for the three months ended June 30, 2026.
- The net change in unrealized appreciation (depreciation) on investments for the three months ended June 30, 2026, was an increase of $427, a slight improvement from a depreciation of $24,142,227 in the prior year period.
Negatives
- Net assets decreased to $(447,081) as of June 30, 2026, from $(235,128) as of December 31, 2025.
- Total investment income for the three months ended June 30, 2026, was $214, a significant decrease from $170,861 in the prior year period.
- The six-month period ended June 30, 2026, resulted in a net investment loss of $177,824.
- There is a substantial net unrealized depreciation of $89,713,527 as of June 30, 2026.
- The company has a going concern warning, with liabilities exceeding assets by $447,081 as of June 30, 2026.
Risks
- The company's investments are primarily in illiquid, privately-held companies and small publicly-traded companies, which carry a higher risk of loss.
- Valuation of privately-held securities is determined in good faith by the Board of Directors, which involves significant estimates and judgments, and may differ materially from realized values.
- The company is subject to market disruption and geopolitical risks, which can adversely impact portfolio companies.
- The company is currently taxed as a corporation and pays federal and state taxes on its taxable income, which impacts net asset value.
- The company has substantial net unrealized depreciation on its investments.
- The company faces litigation, including a case where it was added as a co-defendant in a lawsuit alleging wire fraud and RICO Act violations.
- The company has a going concern warning due to its net asset deficit and operating losses.
Future Outlook
The filing does not provide specific forward-looking guidance but discusses general business prospects, the impact of economic conditions, and the ability to access equity markets. The company acknowledges the uncertainty of future operating results and the potential for impairment of portfolio companies.
Management Comments
- The Fund believes that the allegations in the operative complaint lack merit and has filed an answer denying all wrongdoing. The Fund intends to vigorously defend itself.
- The Fund and the Management Company deny all allegations of wrongdoing in the Star Equity Fund lawsuit.
- Managements plans to mitigate going concern issues include sale of assets, liquidation of Company, infusion of cash from Advisor, raising capital, and reducing overhead costs.
Industry Context
StockSavvy.ai notes that the filing reflects the high-risk nature of investing in early-stage technology and cleantech companies, particularly those that are privately held. The significant unrealized depreciation and going concern warning highlight the extreme volatility and potential for capital loss inherent in this investment strategy, especially in the current economic climate.
Comparison to Industry Standards
- The filing does not provide direct comparisons to industry standards or specific comparable companies regarding financial performance or valuation metrics.
- The company's strategy of investing in illiquid, private, and micro-cap technology companies is a niche within the broader investment management industry, making direct comparison difficult.
- The significant net asset deficit and going concern warning suggest performance significantly below industry norms for stable investment funds.
Legal Proceedings
- VestedCap v. IntraOp Medical Corp., et al.: Lawsuit alleging breach of contract, fraud, conversion, unjust enrichment, judicial foreclosure, wire fraud, RICO Act violations, and alter ego claims. A trial is expected in 2027.
- Star Equity Fund L.P. v. Firsthand Capital Management, Inc., et al.: Lawsuit asserting derivative claims for alleged violations of securities laws, breach of fiduciary duties, and aiding and abetting. An appeal of the dismissal of claims remains pending.
Related Party Transactions
- Payable to affiliates of $300,612 as of June 30, 2026.
- Deferred directors fees payable of $37,500 as of June 30, 2026.
- Kevin Landis, CEO and CFO, serves on the boards of IntraOp Medical Corp., Revasum, Inc., and Wrightspeed, Inc., and as interim CEO at IntraOp Medical Corp. and Wrightspeed, Inc., which may cause conflicts of interest.
Stakeholder Impact
- Shareholders face significant risk of capital loss due to the company's net asset deficit, substantial unrealized depreciation, and going concern warning.
- The ongoing legal proceedings could result in significant financial liabilities and further impact shareholder value.
- The company's ability to continue as a going concern is in doubt, posing a fundamental risk to all stakeholders.
Next Steps
- The company intends to vigorously defend itself in the VestedCap litigation.
- The appeal in the Star Equity Fund lawsuit remains pending.
- Management plans to pursue asset sales, liquidation, capital raises, and cost reductions to address going concern issues.
Key Dates
| Date | Description |
|---|---|
| July 12, 2013 | Acquisition date for IntraOp Medical Corp. Preferred Stock |
| December 31, 2018 | Liquidation of three Cayman subsidiaries completed |
| June 30, 2025 | End of comparative period for financial statements |
| December 31, 2025 | End of prior fiscal year for financial statements |
| June 30, 2026 | End of current reporting period for financial statements |
| August 14, 2026 | Date of report signing |
Recommendation
sellThe filing indicates severe financial distress, including a significant net asset deficit, substantial unrealized depreciation, a going concern warning, and ongoing litigation. These factors collectively present a high level of risk, suggesting a sell recommendation for investors.
Keywords
investment company, venture capital, technology companies, BDC, fair value, unrealized depreciation, going concern
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.